A
-
Aarabi, Mohammad Hadi
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Abadi Marand, Laleh
Effect of dynamic neuromuscular stabilization on fatigue and spasticity in people with multiple sclerosis: a randomized controlled trial (ORP-37) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abbasi, H.
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abin, Ahmad Ali
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abna, Zohreh
Patient monitoring during treatment with natalizumab (ORP-24) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abolhasani, Javad
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Abolhasani, Maryam
Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abolhasani, Maryam
MS and exercise (PP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abrishamchi, Fatemeh
Headache first manifestation of Multiple Sclerosis (PP-19) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Abuga, Imran
Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]
-
Aderinto, Nicholas
Exploring the Potential of Biomarkers for Early Diagnosis and Management of Sporadic Creutzfeldt - Jakob disease; A Review [Volume 2, Issue 2, 2023, Pages 78-86]
-
Adibi, Armin
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Adibi, Iman
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Afshar, Sayeh
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Afshari-Safavi, Alireza
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Aghsaeifard, Masoud
Ophthalmology in multiple sclerosis (ORP-47) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ahadiat, Seyed-Amirabbas
Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
-
Ahadiat, Seyed Amir Abbas
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Ahmadi, Maryam
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ahmadikhonsaraki, Elahe
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Alaie, Shekoofeh
Lower urinary tract dysfunction in Multiple Sclerosis, Updates (ORP-31) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Alayi, Shokoufeh
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Alilou, Sanam
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Alizadeh Amiri, Ali
System biology review of multiple sclerosis and discovery of drug targets (ORP-54) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Amiri Gheshlaghi, Saeed
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Asadi, Bahador
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Asadi-Pooya, Ali Akbar
Management of seizure in patients with multiple sclerosis (ORP-51) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Asadollahzadeh, Elnaz
Escalation or high-efficacy disease-modifying therapies in multiple sclerosis [Volume 2, Issue 2, 2023, Pages 106-108]
-
Asadollahzadeh, Elnaz
Advanced imaging for multiple sclerosis (ORP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Asadollahzadeh, Elnaz
Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran [Volume 3, Issue 1, 2024, Pages 1-2]
-
Ashtari, Atefeh
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Ashtari, Fereshteh
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
Comorbidity in patients with MS (ORP-19) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ashtari, Fereshteh
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Assefi, Marjan
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Ataei, Mitra
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Atafo, Gregory Imoukhuede
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
-
Azadbakht, Javid
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Azami, Mobin
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Azami, Mobin
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Azarsa, Mohammad Hassan
New Technological Approach to Physical Therapy in Patients with Multiple Sclerosis (ORP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Azimi, Elham Sadat
Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Azimzadeh, Kiarash
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Azizabadi Farahani, Maryam
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
B
-
Baghalha, Fatemeh
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Baghbanian, Mohammad
Treatment escalation vs early high efficacy treatment in multiple sclerosis (cons and pros) (ORP-45) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Bahrami, K.
Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Balabandian, Mohammad
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
-
Balabandian, Mohammad
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Balabandian, Mohammad
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
-
Balabandian, Mohammad
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
-
Beladi Moghadam, Nahid
Optic neuritis updates (ORP-57) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Biswas, Nistara
Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
C
-
Chalabianloo, Gholamreza
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
-
Chitsaz, Ahmad
Paroxysmal Events in Multiple Sclerosis (MS); Pseudoathetosis as a Presenting Symptom of MS (ORP-48) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
D
-
Daneshvar, Sam
Proposing Strategies to Increase Pregnancy-Related Awareness Among Multiple Sclerosis Patients in Iran [Volume 3, Issue 1, 2024, Pages 1-2]
-
Davarpanah Jazi, Amirhossein
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Dehghani, Sara
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Doddamani, Rakesh
Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
E
-
Ebadi, Zahra
Physical disability assessment: EDSS calculation (ORP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ebrahimi, Narges
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ebrahimian, Maryam
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Eidi, Atefeh
Review of McDonald criteria (ORP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Emami, Ali
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Emami, Sepideh
Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
-
Eshaghian-Dorcheh, Azam
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Eskandarieh, Sharareh
Epidemiological view of national MS registry in Iran (NMSRI) (ORP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ezenwoba, Chidiogo
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
F
-
Fallahi, Mohammad Sadegh
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Faraji, Ali
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Fatemi, Behzad
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Foroughipour, Mohsen
Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
G
-
Ghabel Damirchi, Behnam
Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
-
Ghaderi, Ali
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
-
Ghaffari, Mehran
Update on inflammation, neurodegeneration and immunoregulation in MS (ORP-44) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ghalamkari, Arshia
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ghalamkari, Arshia
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ghanaati, Hossein
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Ghannadi, Shima
Effect of eight weeks of respiratory muscle training on respiratory capacity, functional capacity, and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis (ORP-33) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Gharemani, Amir Ali
Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Gholamzad, Amir
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Gholamzad, Mehrdad
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Golezar, Mohammad Hossein
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Golipoor, Farhad
MS Prodrome; Is it a fact? (ORP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
H
-
Habibzadeh, Adrina
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Haghshenas Jazi, Mahbobeh
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Hajmanouchehri, Reza
Multiple Sclerosis (MS) and Legal Medical Doctrines (ORP-60) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Halabchi, Farzin
MS and exercise (PP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hamed, Zahra
Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hantooshzadeh, Sedigheh
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Hashemi, Hassan
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Hashemi, Razieh
Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hashemi, Sana
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hashemi, Seyedeh Melika
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Hassani, Sara
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Heidari, Hora
Multiple sclerosis, infectious and Gastrointestinal complications (ORP-39) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Heidari, Hora
Multiple sclerosis, Pregnancy, Breastfeeding (ORP-40) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Heydari, Sanaz
A middle-aged woman with history of Multiple sclerosis presented with sub-acute encephalopathy (ORP-58) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hoseini, Aref
The outcomes of physical activity and health education on cognition level in sedentary seniors [Volume 1, Issue 1, 2022, Pages 32-33]
-
Hoseini Nejad Mir, Nahid
Patients monitoring during treatment with Teriflunomide (ORP-41) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hosseini, Ruhollah
Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
-
Hosseini, Samaneh
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hosseini, Sayed Mohsen
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Hosseini, Seyed Armit
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Hosseinian, Zeinab
Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
-
Hosseinian, Zeinab
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
I
-
Ifemeje, Anthonia
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
-
Ighodaro, Osasumwen Eseosa
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
J
-
Jafari, Majid
Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Jafarlou, Fatemeh
Benign Paroxysmal Positioning Vertigo in Multiple Sclerosis (PP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Jafarlou, Fatemeh
The Effect of Multiple Sclerosis on Peripheral Audio-Vestibular System (PP-17) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Jamali, Raika
Multiple sclerosis and viral hepatitis (ORP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Jameie, Seyed Behnamedin
Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease [Volume 1, Issue 1, 2022, Pages 21-27]
K
-
Kamalakannan, Anupam
Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
-
Kamali, Hoda
Diagnostic approach to autoimmune encephalitis (ORP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
KamaliZonouzi, Sara
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Kamrani, Shirin
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Karimi, Zahra
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Karimi, Zahra
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kavosh, Aryan
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kazemi, Mohamad Ali
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Kazemzadeh, Kimia
Artificial intelligence in multiple sclerosis imaging: advancements, benefits, and challenges (PP-07) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kazemzadeh, Kimia
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kazemzadeh, Kimia
The Role of Artificial Intelligence in Depression Diagnosis, Prognosis, and Treatment: Gaps and Future Directions [Volume 3, Issue 1, 2024, Pages 20-21]
-
Khalili, Elham
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Khatibi, Mahsa
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Khodkam, Maedeh
Neuroimmunoactive biomaterial design [Volume 1, Issue 1, 2022, Pages 17-18]
-
Khodkam, Maedeh
Neuroinflammation and Neurodegenerative disease [Volume 1, Issue 1, 2022, Pages 19-20]
-
Khodkam, Maedeh
Infant frontal EEG asymmetry and prenatal depression: Letter [Volume 1, Issue 1, 2022, Pages 37-38]
-
Khodkam, Maedeh
Guillain-Barré syndrome in remission of Ulcerative colitis: a case report [Volume 2, Issue 1, 2023, Pages 13-15]
-
Khodkam, Maedeh
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Khonche, Sajad
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Khorshidi, Mohammad sadegh
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Khosravi, Atoosa
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kouchaki, Ebrahim
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Kouchaki, Ebrahim
MS Variants (ORP-38) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kouchaki, Ebrahim
The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Kumar Vats, Dimple
Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
L
-
Lawal, Abdulwahab
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
-
Lotfizadeh, Masoud
Investigating the relationship between stress, anxiety and depression with the quality (PP-20) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
M
-
Maghbooli, Zhila
Reduction in Circulating Vitamin D Binding Protein in Patients with Multiple sclerosis (ORP-59) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mahyad, Mahshid
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mahyad, Mahshid
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Malek Zadeh, Mohammadreza
Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Malek Zadeh, Mohammadreza
Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mallahzadeh, Arashk
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
-
Masoud, Seyed-Ali
Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
-
Masoud, Seyed-Ali
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke [Volume 1, Issue 1, 2022, Pages 39-43]
-
Mehdipour, Roshanak
Acute Relapses of Neuromyelitis Optica Spectrum Disorder After COVID-19 Vaccination Shot, Among Iranian Patients (PP-05) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mehrabi, Soraya
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
-
Mehrkian, Saeideh
The importance of vestibular evaluation and rehabilitation in improving the balance in MS patients (ORP-04) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mirmosayyeb, Omid
Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review [Volume 2, Issue 1, 2023, Pages 44-46]
-
Mirmosayyeb, Omid
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Mirmosayyeb, Omid
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mirmosayyeb, Omid
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mirzaasgari, Zahra
Neurology Letters is born! [Volume 1, Issue 2, 2022, Pages 47-47]
-
Mirzaasgari, Zahra
Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
-
Moases Ghaffary, Elham
Optical Coherence Tomography (OCT) Measurements and Disability in Multiple Sclerosis (MS): Protocol of Systematic Review [Volume 2, Issue 1, 2023, Pages 44-46]
-
Moases Ghaffary, Elham
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Moases Ghaffary, Elham
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Moases Ghaffary, Elham
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Moeini, Omid
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Moghadasi, Mehdi
MS and Environmental Factors (ORP-61) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mohaghegh, Maryam
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mohammadi, Mobin
The Prevalence of Multiple Sclerosis Relapse following COVID-19 infection vs COVID-19 Vaccine [Volume 3, Issue 1, 2024, Pages 3-11]
-
Mokary, Yousef
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mokary, Yousef
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mokary, Yousef
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Moradi, Behnaz
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Motahharynia, Ali
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Motamed, Mohammadreza
Multiple sclerosis and legal medicine (ORP-34) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Motamedi-Jahromi, Aria
Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report [Volume 1, Issue 1, 2022, Pages 34-36]
-
Mousavi, Taraneh
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mousavian, Pourandokht
Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Mozhdehipanah, Hossein
Everything we need to know about vaccination in MS (ORP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
N
-
Nabavi, Seyed Massood
Horizons of MS therapy: during 30 years (ORP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nabizadeh, Fardin
What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease? [Volume 1, Issue 1, 2022, Pages 1-11]
-
Nabizadeh, Fardin
Biomaterials in The Treatment of Amyotrophic Lateral Sclerosis [Volume 1, Issue 1, 2022, Pages 12-16]
-
Nabizadeh, Fardin
Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease [Volume 1, Issue 1, 2022, Pages 21-27]
-
Nabizadeh, Fardin
Neurology Letters is born! [Volume 1, Issue 2, 2022, Pages 47-47]
-
Nabizadeh, Fardin
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
-
Nabizadeh, Fardin
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Nabizadeh, Fardin
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
-
Nabizadeh, Fardin
COVID-19 vaccine-hesitancy is associated with lower cortical volume in elderly individuals [Volume 2, Issue 1, 2023, Pages 35-41]
-
Nabizadeh, Fardin
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Nabizadeh, Fardin
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nabizadeh, Fardin
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Naghavi, Saba
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Naghavi, Saba
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Naghavi, Saba
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Naghavi, Saba
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nahayati, Mohammadali
Treatment approach in Autoimmune encephalitis (ORP-36) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nahayati, Mohammad Ali
Alopecia universalis in a patient under treatment of Ocrelizumab after switching from Rituximab (PP-06) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nahayati, Mohammad Ali
Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nahayati, Mohammad Ali
Diagnosis of multiple sclerosis and Fahr's Disease in a young woman: A case report (PP-15) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nahayati, Mohammad-Ali
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Najafi, Mohammad Amin
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Najafi, Mohammad Amin
Acute disseminated encephalomyelitis (ADEM), Report A Rare Case of Refractory form to treatment (PP-03) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Najafi, Mohammad Reza
EEG Patterns in MS-related epilepsy A literature Review (ORP-26) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Namvari, Alireza
Helicobacter Pylori specific antibodies among multiple sclerosis patients [Volume 1, Issue 1, 2022, Pages 28-31]
-
Nankali, Alireza
Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Naser Moghadasi, Abdorreza
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Naser Moghadasi, Abdorreza
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nasibi, Seyede Maryam
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
-
Navardi, Samira
Optic neuritis and autoimmune optic neuropathies (ORP-35) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nejadghaderi, Seyed Aria
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
-
Niakosari, Vida
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nikfar, Shekoufeh
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nikkhah, Karim
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Niknam, Zahra
Mind and Art (ORP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nikoo, Zahra
Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Nourikhani, Mohammadmatin
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Nwakama, Chijindu
An Overview of The Harmful Cultural Practices on Epilepsy in Sub-Saharan Africa and Their Impact on Its Clinical Management [Volume 3, Issue 1, 2024, Pages 22-26]
-
Nyundo, Jasmit
Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]
O
-
Olatunji, Gbolahan
Exploring the Potential of Biomarkers for Early Diagnosis and Management of Sporadic Creutzfeldt - Jakob disease; A Review [Volume 2, Issue 2, 2023, Pages 78-86]
-
Oyungu, Juzar
Autonomic dysfunction and fatigue in Parkinson’s disease: a report from Kenya [Volume 2, Issue 1, 2023, Pages 47-50]
P
-
Panahi, Delaram
Guillain-Barré syndrome in remission of Ulcerative colitis: a case report [Volume 2, Issue 1, 2023, Pages 13-15]
-
Pandian, Preethi
Review Current and Emerging Treatment Options for Alzheimer's Disease [Volume 2, Issue 1, 2023, Pages 1-5]
-
Pang, Sen
The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]
-
Pathak, Lokesh
Personalized Treatment for Multiple Sclerosis: The Role of Precision Medicine [Volume 2, Issue 1, 2023, Pages 30-34]
-
Paybast, Sepideh
How to estimate the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis? (ORP-43) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Paybast, Sepideh
Is There a Need to Differentiate Atypical Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorders (NMOSD)? The Pros and Cons: A Systematic Review (PP-21) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Payere, Maryam
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pirahesh, Kasra
Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report [Volume 1, Issue 1, 2022, Pages 34-36]
-
Pirahesh, Kasra
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Pirzad, Razieh
Multidisciplinary rehabilitative management (PP-24) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pourakbar, Ebrahim
Acute disseminated encephalomyelitis following vaccination against SARS-cov-2: a case report (PP-04) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pour Moghtader, Keysan
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Pourmohammadi, Ahmad
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pourmohammadi, Ahmad
Relationship between severity of symptoms of sleep disorders and information processing speed in people with multiple sclerosis (ORP-53) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pourmohammadi, Ahmad
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Pourmohammadi, Ahmad
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Poursadeghfard, Maryam
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Poursadeghfard, Maryam
Definition and treatment of the multiple sclerosis relapse (ORP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Poursadeghfard, Maryam
Neuromyelitis Optica Spectrum Disorders (NMOSD); Diagnostic criteria (ORP-56) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
R
-
Rafiei, Nazanin
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Rahmati, Ali
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rahmatian, Aryobarzan
Comparison of the Effect of Botulinum Toxin Injection Under Ultrasound Guidance and Oral Propranolol in the Treatment of Moderate to Severe Essential Hand Tremor [Volume 2, Issue 2, 2023, Pages 69-77]
-
Ramazani, Neda
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ramezani, Neda
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Ramezannezhad, Elham
Role of Biomaterials in treatment of Alzheimer’s disease: A literature review [Volume 1, Issue 2, 2022, Pages 64-68]
-
Ramezannezhad, Elham
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rashidi Alavijeh, Mehran
Early Clinical Response and Complications of Therapeutic Plasma Exchange in Central Nervous System Demyelinating Diseases (PP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rasouli, Kimia
The outcomes of physical activity and health education on cognition level in sedentary seniors [Volume 1, Issue 1, 2022, Pages 32-33]
-
Razazian, Nazanin
Patient Monitoring during Treatment with Ocrelizumab and Rituximab (ORP-49) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Reza, Mohammad Amin
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rezaeimanesh, Nasim
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Rezaeimanesh, Nasim
A narrative review on the dietary interventions in multiple sclerosis (ORP-03) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rezaeimanesh, Nasim
Nutritional recommendations in multiple sclerosis patients: a narrative review (ORP-46) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rizvi, Priya
Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
-
Roozbeh, Mehrdad
Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Rostami, Mahya
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Rostami, Mohammad Reza
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
S
-
Sadeghi, Hadis
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases [Volume 2, Issue 2, 2023, Pages 55-68]
-
Sadeghi, Mehdi
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Saeidi, Morteza
Gut-Brain axis and MS: Is this true? (ORP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Safa, Nasim
The effects of crocin on inflammatory biomarkers and mental health in patients with multiple sclerosis: a randomized, double-blinded clinical trial (ORP-63) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sahraian, Mohammad Ali
A Systematic Review and Meta-analysis on Safety and Effectiveness of Extended-interval Dosing of Natalizumab in Patients with Relapsing-remitting Multiple Sclerosis: Is There Any Value in The Cost of Treatment? (PP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sanati, Mohammad Hossein
Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sanayei, Mehdi
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sanayei, Mehdi
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sayadnasiri, Mohammad
Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
-
Sedighi, Behnaz
Women and Multiple Sclerosis (ORP-07) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sedighi, Mohsen
Regional cerebral blood flow and brain atrophy in mild cognitive impairment and Alzheimer's disease [Volume 2, Issue 1, 2023, Pages 16-24]
-
Sehgal, Debabrata
Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
-
Seyedesfahani, Behrad
Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
-
Shaafi, Sheida
Quantitative Electroencephalography Findings in Treatment-resistant and Responsive Patients with Idiopathic Generalized Tonic-Clonic Epilepsy [Volume 2, Issue 1, 2023, Pages 6-12]
-
Shafiee, Mohammad
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Shafiei, Seyyed Hossein
Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shahmaei, Vahid
The Role of Advanced MRI Techniques and Artificial Intelligence-based Methods In Diagnosis of Multiple Sclerosis (ORP-42) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shahzadi, Sohrab
The role of stereotactic biopsy in atypical brain lesions (ORP-52) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shakiba, Shima
Cognitive Functions of Patients with Post Stroke Depression: Comparative Study on Executive Functions, Processing Speed, and Episodic Memory [Volume 2, Issue 2, 2023, Pages 87-96]
-
Shamlou, Farid
Lingual dystonia as the first manifestation of multiple sclerosis (PP-22) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shams, Shirin
Acute Brainstem syndrome with NMOSD and related to systemic lupus erythematosus, A Rare Case Report (PP-02) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sharafi, Amir Mohammad
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
-
Sharafshah, Alireza
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Shaygannejad, Aysa
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shaygannejad, Vahid
Spinal cord MRI in multiple sclerosis; diagnostic, prognostic, and clinical value (ORP-55) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shaygannejad, Vahid
A Mechanistic Insight into Sources of Error of Visual Working Memory in Multiple Sclerosis (PP-01) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shaygannejad, Vahid
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shaygannejad, Vahid
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shiati, Samin
Current Updates on the Use of Probiotics as a New Treatment Option for Multiple Sclerosis (ORP-50) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shirazi, Mahboobeh
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Shokri Shakib, Soheil
Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy diagnosis and management: A case report study (ORP-28) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Shreyashi, Gunjan
Restless Leg Syndrome and Impulse-Control Disorders in Parkinson’s Disease: Observational study [Volume 2, Issue 1, 2023, Pages 51-54]
-
Shriati, Mohammad
Demyelinating etiology as a possible cause of Parry–Romberg Syndrome (PP-14) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Sodeifian, Fatemeh
Juvenile amyotrophic lateral sclerosis in 16 years old girl with HIV [Volume 1, Issue 1, 2022, Pages 44-46]
-
Sodeifian, Fatemeh
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review [Volume 1, Issue 2, 2022, Pages 48-60]
-
Sodeifian, Fatemeh
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review [Volume 1, Issue 2, 2022, Pages 69-77]
-
Soleimani, Mohammad
Femoral head AVN concept and treatments (ORP-16) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
T
-
Tabibian, Farinaz
Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Tabrizi, Nasim
Cardiovascular autonomic dysfunction in MS (PP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Taghdisi Kashani, Alireza
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Talebi, Mahnaz
MS and cognition: review of clinical, neuro-radiological features, and treatment (ORP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
V
-
Vafaei, Seyedeh Maryam
Can helicobacter pylori infection reduce the risk of Multiple sclerosis? A systematic review and meta-analysis [Volume 2, Issue 2, 2023, Pages 97-105]
-
Vaheb, Saeed
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
W
-
Waheed, Yasir
Level of CSF GAP-43 and white matter microstructural changes in Alzheimer's disease [Volume 3, Supplementary 1 (Diagnostic and Therapeutic advances in Neurodegenerative diseases), 2024, Pages 1-6]
-
Wang, Hairui
Current understanding of the association between Amyotrophic lateral sclerosis and frontotemporal dementia: Letter to Editor [Volume 2, Issue 1, 2023, Pages 42-43]
-
Wen-Yi, Jing
The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]
Y
-
Yazdani, Sara
Long-term and Short-term Episodic Memory Dysfunction in Female MS Patients (PP-18) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Yazdan Panah, Mohammad
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Yazdan Panah, Mohammad
Sleep Disturbances and Disease Characteristics of Patients with Multiple Sclerosis in Iran: A Cross-sectional Study (ORP-32) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Yazdan Panah, Mohammad
Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Yousefipour, Gholamali
Case presentation, Atypical imaging of MS (PP-11) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Yousefi Pour, Ali
Patients monitoring during treatment with Dimethyl fumarate (ORP-23) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
Z
-
Zaer Rezaei, Hanieh
Care ethics and empathic Practices in dealing with MS Patients (ORP-62) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Zafari, Rasa
Neuroimaging findings of COVID-19: a systematic review on longitudinal studies [Volume 3, Issue 1, 2024, Pages 27-36]
-
Zandieh, Ghazal
Comparing the Impact of Bariatric Surgery and Diet Therapy on MS Disease-Related Symptoms: A Systematic Review Study (PP-12) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Zare Bidoki, Fatemeh
Comparing the Diagnostic Yield of Antenatal Fetal Ultrasound, Neurosonography, and MRI for Detecting CNS Anomalies: A Prospective Study [Volume 3, Issue 1, 2024, Pages 12-19]
-
Zarvani, Ashraf
Cardiovascular autonomic dysfunction in MS (PP-10) [Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), 2023]
-
Zeinali, Marjan
Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
-
Zhang, Jie
Current understanding of the association between Amyotrophic lateral sclerosis and frontotemporal dementia: Letter to Editor [Volume 2, Issue 1, 2023, Pages 42-43]
-
Zi, Wu
The Interplay Between the Gut Microbiome and Neurological Disorders: Exploring the Gut-Brain Axis [Volume 2, Issue 1, 2023, Pages 25-29]
-
Ziaee, Mahsa
Transient global amnesia associated with acute bacterial endocarditis; A case report [Volume 1, Issue 2, 2022, Pages 61-63]
Your query does not match with any item